| Name | Title | Contact Details |
|---|
thewindwardgroup.net is your first and best source for all of the information you’re looking for. From general topics to more of what you would expect to find here, thewindwardgroup.net has it all. We hope you find what you are searching for!
The first people management software designed specifically to develop leaders at every level of your organization.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Alvenda is a company thats works to create a social commerce channel on Facebook as well as numerous other websites.